News
Manchester drives groundbreaking collaboration for first in man trials
17 May 2013As International Clinical Trials day (May 20th) is celebrated around the world, Manchester scientists are driving two groundbreaking early-phase trials that buck tradition by bringing together Asian and Western research sites.
Manchester appoints world-leading academic to help bring graphene closer to medicine
7 May 2013The University of Manchester has today announced the appointment of a world-leading academic, who is playing a pivotal role in nanomedicine - a growing field with potential to benefit patients suffering from neurodegenerative disease and cancer.
Some types of papilloma virus might prevent cervical cancer
10 April 2013Certain types of papilloma virus might actually prevent cervical cancer, according to a new study by researchers from The University of Manchester.
Scientists find a near doubling of breast, ovarian and prostate cancer markers
27 March 2013Scientists, including experts at The University of Manchester, have found a near doubling of the number of markers associated with breast, ovarian, and prostate cancer.
Teenage and young adult cancer deaths almost halved in last 30 years but success masks lack of access to clinical trials
25 March 2013The number of teenagers and young adults dying from cancer in Britain has fallen from around 580 per year in the mid-70s (1975-77) to around 300 today (2008-2010), according to a new Cancer Research UK report.
The Business of Beating Cancer
20 March 2013The North West’s leading entrepreneurs have gathered to discuss how business can beat cancer.
Funding boost for research into pancreatic cancer
12 March 2013The Pancreatic Cancer Research Fund has today (Tuesday 12 March) announced it is funding a £150,000 research project at Cancer Research UK’s Paterson Institute based at The University of Manchester.
Taking omega-3 fish oils could help to protect against skin cancer, according to researchers at The University of Manchester
26 February 2013The team has just carried out the first clinical trial to examine the impact of the fish oils on the skin immunity of volunteers.
Understanding why cells stick
15 February 2013Research carried out by scientists at Georgia Institute of Technology and The University of Manchester has revealed new insights into how cells stick to each other and to other bodily structures, an essential function in the formation of tissue structures and organs.
Researchers in Manchester find genetic key to preventing spine tumours
15 February 2013Genetic medicine experts from Manchester Biomedical Research Centre at Saint Mary’s Hospital and The University of Manchester have identified a new gene responsible for causing an inherited form of tumour, known as spinal meningioma.
Academics launch new clinically approved diet
14 February 2013Two academics from The University of Manchester have come up with a new diet which they believe can help lower the risk of breast cancer.
Two drugs better than one to treat most deadly skin cancer
11 February 2013Adding lung cancer drugs to targeted melanoma treatment could increase survival for certain patients, according to research published in Cancer Discovery today (Monday 11 February).
Breast cancer stem cells can be targeted to stop disease
4 February 2013In a significant breakthrough scientists prove for the first time that breast cancer stem cells, the driving force of a tumour, can be targeted in cells from patients; an approach that could increase the chances of survival for women with aggressive breast cancers.
Yeast scientists reveal a novel player in the orchestra of the cell cycle
4 February 2013Defective regulation of the cell cycle leading to uncontrolled growth is one of the hallmarks of cancer.
Better approach to treating deadly melanoma identified by scientists
19 December 2012Scientists at The University of Manchester have identified a protein that appears to hold the key to creating more effective drug treatments for melanoma, one of the deadliest cancers.
Scientists show that for yeast cell division it’s not what you do it’s where you do it
9 December 2012A new paper published this month demonstrates that when it comes to activating cell division, location is everything.
Scientist awarded €150K prize for non-invasive cancer tests
28 November 2012A scientist from The University of Manchester has been awarded a €150,000 (about £120,000) research prize for the development of scalpel-sparing tests for the diagnosis and management of cancer.
Cancer survivors dig for a future with ‘Breaking the Ground’
8 November 2012Inspirational cancer survivors will take the first step in helping to build a new £28.5m research building for the Manchester Cancer Research Centre (MCRC) today (Thursday).
Multimillion pound funding boost for cancer research
1 November 2012Cancer research in Manchester has been given a £12.8 million funding boost following a successful bid by The University of Manchester to the UK Research Partnership Investment Fund (UKRPIF).
Scientists unravel resistance to breast cancer treatment
1 November 2012Scientists have identified a molecular ‘flag’ in women with breast cancer who do not respond or have become resistant to the hormone drug tamoxifen.
Prostate cancer prognosis hope
29 October 2012Scientists have discovered a molecular ‘tell’ in laboratory experiments that could help doctors determine the severity of a patient’s prostate cancer.
Council chief to be next Chair of Manchester health partnership
29 October 2012Manchester City Council’s Chief Executive Sir Howard Bernstein will be the next Chair of the Manchester Academic Health Science Centre (MAHSC).
Scientists harness immune system to prevent lymphoma relapse
18 October 2012UK scientists hope that lymphoma patients could benefit from a new drug that triggers the cancer-fighting properties of the body’s own immune system, after highly promising early laboratory results.
Scientists develop improved imaging technique for brain tumours
27 August 2012Scientists have developed a more accurate technique for imaging brain tumours that explains why different parts of the tumour have a different response to some anticancer drugs.
Scientists present new insights into the regulation of cell division
27 August 2012A study of mechanisms that regulate cell division will better our understanding of the basic molecular processes that may lead to cancer.
Manchester scientists give new life to old samples
7 August 2012Manchester scientists have found a new way of getting valuable information from tissue samples – even from those that have been stored for a long time and have started to reach the end of their shelf-life.
PhD student receives Jack Fowler award
18 July 2012Joana Senra, a final year PhD student in Ian Stratford’s group in the School of Pharmacy & Pharmaceutical Sciences has been awarded the Jack Fowler award for her work on targeting DNA damage response pathways to improve the outcome of radiotherapy.
Scientists identify risk factor for relapse of childhood leukaemia
9 July 2012Manchester scientists have identified a new risk factor associated with a high risk of relapse for childhood leukaemia.
DNA repair protein identified by scientists
6 July 2012Scientists have found a novel DNA repair protein providing fresh insight into the processes of DNA damage that can lead to cancer.
Scientists identify a new mechanism of cell cycle regulation
11 June 2012Scientists have discovered a new regulatory mechanism of cell cycle progression, giving insights into the mechanisms that may cause cancer.
Manchester scientists find new ways of making cancer cells more sensitive to radiotherapy
10 May 2012Manchester scientists have synthesised new compounds that can make tumour cells more sensitive to radiotherapy and that could be used to improve cancer treatment.
Clinical Scientist receives national award
20 April 2012One of The Christie's clinical scientists, Carl Rowbottom, has received the Chief Scientific Officer's Award for Leadership in the prestigious Advancing Healthcare Awards.
Royal opens Patient Treatment Centre
11 April 2012His Royal Highnesses The Earl of Wessex officially opened The Christie's Oak Road Patient Treatment Centre on Wednesday 11 April 2012.
World's most advanced form of radiotherapy coming to Manchester
5 April 2012The Department of Health has confirmed that up to £250m will be invested in building Proton Beam Therapy facilities at The Christie and University College London Hospitals NHS Foundation Trust.
Plans for new cancer research centre given green light
15 March 2012Plans to build a state-of-the-art cancer research building for the Manchester Cancer Research Centre (MCRC) have been approved by Manchester City Council’s planning committee.
Skin cancer drug trialled at The Christie now licensed in UK
14 March 2012Zelboraf (vemurafenib), the first personalised treatment to extend life of patients with BRAF V600 mutation positive unresectable or metastatic melanoma to over a year, is now licensed for use in the UK following accelerated review by the EU Commission.
NIHR Clinical Research Facility Funding for The Christie
2 March 2012The Christie successfully obtained £4.5M funding from the National Institute for Health Research (NIHR) for its Phase I/II Cancer Trials Unit in recognition of the outstanding early phase research work already carried out.
New Paterson Institute Director
1 February 2012Professor Richard Marais, the new Director of the Paterson Institute for Cancer Research, took up his post on 1 February 2012.
National Advisory Group on Radiotherapy
30 January 2012Dr Nick Slevin has been appointed as the Chair of a new national advisory group on radiotherapy.
New Clinical Director for The Christie Clinical Trials Unit
30 January 2012Dr Andrew Wardley has been appointed director of the Clinical Trials Unit at The Christie.
